Arcadia Biosciences Inc (RKDA) Actualités

Form 8-K - Current report

Form 8-K - Current report

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights

-- Year-over-year revenues grew 56% in Q4 and 13% for full year -- -- Zola® year-over-year revenues increased 124% in Q4 and 46% for full year...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Arcadia Biosciences, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Arcadia Biosciences, Inc. PR Newswire NEW YORK, Dec. 6, 2024 NEW YORK, Dec. 6...

Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction

-- Companies to host a joint investor call on December 11, 2024 at 4:30 p.m. ET -- Arcadia Biosciences, Inc.®...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights

– Total revenues increased 18% compared to Q3 2023 – – Zola® coconut water revenues grew 55% year over year – – Zola retail distribution expanded...

Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that...